GDF-8 Overview
Mechanism of Action
GDF-8 propeptide is the naturally occurring inhibitor of myostatin (Growth Differentiation Factor-8). Myostatin is a TGF-β family member that powerfully inhibits skeletal muscle growth. The propeptide binds and sequesters active myostatin, preventing receptor signaling. This releases the brake on muscle protein synthesis, satellite cell activation, and muscle fiber hypertrophy.
Estimated several hours
Timing
Post-workout may optimize effects
Injection Site
Subcutaneous
Food
Protein-rich diet recommended
Common Stacks
- BPC-157/TB-500 — Recovery support
- GH peptides — Comprehensive anabolic support
GDF-8 Dosing Protocol
Standard Protocol
8–12 weeks100–500 mcg SQ 2–3x/week
Limited human dosing data.
GDF-8 Expected Timeline
Week 2–4
Myostatin levels decrease
Week 4–8
Enhanced muscle protein synthesis
Week 8–12
Measurable lean mass gains
GDF-8 Side Effects
Limited human safety data
Injection site irritation
GDF-8 Research Studies
Myostatin mutation associated with gross muscle hypertrophy in a child
Schuelke M, et al. — N Engl J Med (2004)
Case report of a child with loss-of-function myostatin mutation displaying extraordinary muscularity, confirming myostatin as the primary negative regulator of muscle mass.
PubMed: 15190455GDF-8 FAQ
What happens when myostatin is blocked?
Belgian Blue cattle (myostatin mutation) exhibit extreme muscularity. A human child with the mutation showed extraordinary muscle development. Pharmacological inhibition aims to partially replicate this.
Is myostatin inhibition safe long-term?
Complete genetic knockout is well-tolerated in animals. Partial pharmacological inhibition shows acceptable safety in trials but long-term human data is limited.